CCDR: Volume 46-4 -April 2020: Respiratory syncytial virus (RSV)

CCDR: Volume 46-4 -April 2020: Respiratory syncytial virus (RSV) The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. 2020-04-06 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetyVaccineNational Advisory Committee on ImmunizationNACIimmunizationRSVrespiratory syncytial virusmumpsoutbreakincidencevaccinationMMR vaccineinvestigationimmunityManitobameaslestravel healthsurveillancemeasles eliminationvaccinationtuberculosisMycobacterium tuberculosisdrug susceptibility testisoniazid-resistantmultidrug-resistantvaccine hesitancymotivational interviewingvaccine acceptancevaccine uptakeparental concernscovidcoronavirus CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV)HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020.html CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV)HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020.html CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV)PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04f-fra.pdf CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV)PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04-eng.pdf Overview of the respiratory syncytial virus vaccine candidate pipeline in CanadaHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-1-challenges-developing-vaccine-respiratory-syncytial-virus.html Overview of the respiratory syncytial virus vaccine candidate pipeline in CanadaHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-1-defis-matiere-creation-vaccin-contre-virus-respiratoire-syncytial.html Overview of the respiratory syncytial virus vaccine candidate pipeline in CanadaPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a01-eng.pdf Overview of the respiratory syncytial virus vaccine candidate pipeline in CanadaPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a01f-fra.pdf Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreatHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-2-report-canada-readiness-rsv-vaccines.html Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreatHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-2-rapport-preparation-canada-vaccins-vrs.html Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreatPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02-eng.pdf Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreatPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02f-fra.pdf Infographic: Summary of RSV vaccine products in late-stage developmentHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-2a-respiratory-syncytial-virus-vaccine-products.html Infographic: Summary of RSV vaccine products in late-stage developmentHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-2a-produits-vaccinaux-contre-virus-respiratoire-syncytial.html Infographic: Summary of RSV vaccine products in late-stage developmentPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02a-eng.pdf Infographic: Summary of RSV vaccine products in late-stage developmentPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a02af-fra.pdf Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-3-mumps-outbreak-manitoba-canada-2018-2019.html Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-3-eclosion-oreillons-manitoba-canada-2018-2019.html Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a03-eng.pdf Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a03f-fra.pdf Measles surveillance in Canada: 2018 HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-4-report-measles-canada-2018.html Measles surveillance in Canada: 2018HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-4-rapport-rougeole-canada-2018.html Measles surveillance in Canada: 2018PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a04-eng.pdf Measles surveillance in Canada: 2018PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a04f-fra.pdf Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-5-clinical-risk-factors-drug-resistant-tuberculosis-ontario-canada-2010-2016.html Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-5-facteurs-risque-cliniques-tuberculose-multiresistante-ontario-canada-2010-2016.html Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a05-eng.pdf Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a05f-fra.pdf Motivational interviewing: A powerful tool to address vaccine hesitancyHTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-6-canvax-addressing-vaccine-hesitancy.html Motivational interviewing: A powerful tool to address vaccine hesitancyHTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-6-canvax-vaincre-reticence-vaccination.html Motivational interviewing: A powerful tool to address vaccine hesitancyPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a06-eng.pdf Motivational interviewing: A powerful tool to address vaccine hesitancyPDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a06f-fra.pdf Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19)HTML https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/article-7-id-news.html Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19)HTML https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2020-46/numero-4-2-avril-2020/article-7-actualites-maladies-infectieuses.html Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19)PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a07-eng.pdf Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19)PDF https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-4-april-2-2020/ccdrv46i04a07f-fra.pdf

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.

Data and Resources

Similar records